This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
In June 2022, we reviewed the evidence and made new re...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus Tipo 2,
Diabetes Mellitus,
Biomarcadores/sangue,
Glicemia/metabolismo,
Angiopatias Diabéticas/prevenção & controle,
Frutosamina/sangue,
Hemoglobinas Glicadas/metabolismo,
Hipoglicemiantes/uso terapêutico,
Expectativa de Vida,
Preferência do Paciente,
Assistência Centrada no Paciente,
Hemoglobinas Glicadas,
Hipoglicemiantes
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Glicemia,
Terapia Combinada,
Diabetes Mellitus Tipo 1,
Diabetes Mellitus Tipo 2,
Dieta para Diabéticos,
Monitoramento de Medicamentos,
Endocrinologia,
Hiperglicemia,
Hipoglicemia,
Insulina/uso terapêutico,
Sistemas de Infusão de Insulina,
Monitorização Ambulatorial,
Educação de Pacientes como Assunto,
Medicina de Precisão,
Diabetes Mellitus Tipo 1/tratamento farmacológico,
Diabetes Mellitus Tipo 2/tratamento farmacológico,
Diabetes Mellitus Tipo 1/terapia,
Diabetes Mellitus Tipo 2/terapia,
Hipoglicemiantes/uso terapêutico,
Hipoglicemiantes/efeitos adversos,
Insulina/efeitos adversos
Criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999....
